A148 EBV STATUS AND IMMUNOSUPPRESSANT USE IN IBD PATIENTS WHO SUBSEQUENTLY DEVELOP LYMPHOMA: A RETROSPECTIVE AND PROSPECTIVE STUDY

BACKGROUND: Immunosuppressive agents have revolutionized the treatment of inflammatory bowel disease (IBD). However, a number of studies over the last decade have identified a concerning link between immunosuppression and lymphoproliferative disorders (LPDs). These LPDs have been associated with Eps...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Can Assoc Gastroenterol
Autori principali: Reeson, M, Ambrosio, L, Lam, G Y, Fedorak, R, Dieleman, L A, Kroeker, K I, Huang, V, Peters, A, Halloran, B P
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2018
Soggetti:
Paper Sessions
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6508111/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy009.148
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi